Wayne, N.J.-based Konica Minolta said that the deal will help the company continue to develop solutions for specialists to deliver the best care possible with cutting-edge ultrasound tech in out-of-hospital settings.
“The unique relationship with Mindray further underscores Konica Minolta’s commitment to being a market leader in MSK ultrasound,” Konica Minolta’s ultrasound division senior VP and general manager Brian Noyes said in prepared remarks. “Mindray’s dedication to improving patient care complements Konica Minolta’s cutting-edge technologies and award-winning customer satisfaction.”
“It’s important to place excellent technology in the hands of MSK experts who can support orthopedists, sports medicine physicians, rheumatologists, podiatrists and beyond. Konica Minolta has extensive experience in this field and is a longstanding provider of MSK solutions to this group of specialists,” Mindray Ultrasound’s chief product officer Glen McLaughlin added. “By working together, industry experts bring value to musculoskeletal providers by giving them the best tools at the point of care.”
In March of this year, Mindray closed a $3.3 billion go-private deal the Chinese medical device company inked with its managers. The $28-per-share deal means MR shares have since ceased trading on the New York Stock Exchange.
Last year, Konica Minolta partnered with pan-Asian life insurance group AIA Group Ltd. to launch a digital health accelerator in Singapore. The 12-week AIA – Konica Minolta Digital Health Accelerator aimed to support entrepreneurs and businesses that deliver solutions through integrating data into healthcare delivery, the companies said.